The FRAIL-M Study was successfully showcased at the ALLG Scientific Meeting November 2019 recently.
This presentation highlights the collaboration and logistics between ALLG, AMaRC, CHERE and MRDR amongst other partnerships with the study.
The progress of other AMaRC trials were also reported to the working parties of the scientific meeting as well and was generally well-received by the audience.
The FRAIL-M Study:
The Belantamab-K Study:
The IRIL Study:
The KappaMab Study:
